ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,303, issued on July 8, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh).
"Oncolytic virus therapy" was invented by Zong Sheng Guo (Wexford, Pa.), David Bartlett (Pittsburgh), Zuqiang Liu (Wexford, Pa.) and Mathilde Feist (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "The presently disclosed subject matter relates to tumor infiltrated T cells induced by oncolytic virus ("OV-induced T cells"), methods of making and using said OV-induced T cells for an adoptive T-cell therapy. The presently disclosed subject matter further relates to oncolytic viruses and armed oncolytic viruses, methods of...